Glendon E. French has been leading Pulmonx Corporation since 2020, guiding the company during a challenging period in the healthcare sector. His leadership saw the company through various events, impacting its stock value significantly. For example, French was involved in...

Glendon E. French has been leading Pulmonx Corporation since 2020, guiding the company during a challenging period in the healthcare sector. His leadership saw the company through various events, impacting its stock value significantly. For example, French was involved in notable insider trades, peaking in April 2021 with dealings worth around $56 million. His compensation package reflected a heavy reliance on performance metrics, with a 2022 total compensation reported at approximately $4.6 million, including a significant bonus based on achieving corporate performance targets. However, there have been ups and downs, with substantial fluctuations in the stock value of Pulmonx. In 2023, his base salary was set at $580,000, maintaining a strong incentive structure that included options tied to performance. The company has also focused on improving governance, emphasizing diversity within its board, and adopting a stock ownership policy for its executives. Overall, French's tenure as CEO has been marked by considerable shifts in the company's fortunes, aligned with broader industry challenges and performance goals.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Pulmonx Corporation CEOs

P

Glendon E. French

Ex-CEO of Pulmonx Corporation

Sector of Economy

Healthcare

CEO of Pulmonx Corporation for

4 years 0 months (Mar 2020 - Mar 2024)

Previous Experience

President and Chief Executive Officer of Pulmonx Corporation

Rivals

Competitors/colleagues of Glendon E. French

Holdings

See how much did Glendon E. French make over time.

As of March 2023, Glendon E. French held around 1.2 million shares of Pulmonx Corporation, about 3.2% of the company's total stock. His holdings peaked in value in early 2021, reflecting the company's upward momentum at that time. However, this...

As of March 2023, Glendon E. French held around 1.2 million shares of Pulmonx Corporation, about 3.2% of the company's total stock. His holdings peaked in value in early 2021, reflecting the company's upward momentum at that time. However, this value saw a significant downward trend over the following years due to fluctuations in stock market conditions and the company's performance metrics. His major stock options were highly tied to the company’s strategic goals, showing that he has a vested interest in the long-term success of Pulmonx. The span from mid-2021 to early 2022 showcased a dramatic decline in the market value of his holdings, indicating the challenges faced by the company amid a volatile market. His wealth composition shows a gradual decrease in value, showcasing the importance of aligning leadership interests with shareholder performance.

Total Stock Sold

$16.40M

LUNG

$16.40M

556,224 LUNG shares

What if they kept their stock?

If Glendon E. French didn't sell their stock, today they would have:
Extra LUNG556,224 shares worth $21.87M.
This is 33.34% and $5.47M more than what they got when they sold the stock.

Charitable Transactions

LUNG

25,000 shares

LUNG

Recent Charitable Transactions

LUNG

25,000 shares

LUNG

May 16, 2022

Charity

Insider Trading

See recent insider trades of Glendon E. French.

LUNG

$161.80K

LUNG at $8.09/share

Sep 12, 2024

Sale

LUNG

15,216 shares

LUNG

Jun 3, 2024

Received

LUNG

$63.00K

LUNG at $9.06/share

Mar 1, 2024

Sale

LUNG

$292.00K

LUNG at $14.60/share

Feb 15, 2024

Sale

LUNG

$127.70K

LUNG at $12.77/share

Jan 18, 2024

Sale

LUNG

$124.20K

LUNG at $12.42/share

Dec 21, 2023

Sale

LUNG

$69.03K

LUNG at $10.34/share

Dec 1, 2023

Sale

LUNG

$65.34K

LUNG at $10.01/share

Sep 1, 2023

Sale

LUNG

$190.20K

LUNG at $12.68/share

Jul 20, 2023

Sale

LUNG

$126.80K

LUNG at $12.68/share

Jun 15, 2023

Sale

Compensation History

See how much did Glendon E. French make over time.

In 2023, Glendon E. French's total compensation amounted to approximately $580,000, including a base salary and various stock options. His earnings strategy ties directly to Pulmonx's performance metrics, with a past peak of around $4.8 million in 2021. French’s pay structure is designed to align with the company’s performance, emphasizing results and shareholder interests. Over the past three years, his compensation has fluctuated significantly, revealing a pattern of adaptive responses to the company's financial outcomes. His lack of bonuses in certain years indicates a strict performance standard that he must meet to earn additional rewards. This structure shows a strong focus on long-term value generation rather than short-term gains, aiming to drive the company towards more substantial growth.

Year

2023

Total Compensation

$580.67K

Salary

$580.00K

Board Justification

The company's compensation philosophy aims to align executive compensation with performance and shareholder interests, focusing on long-term value creation.

Bonus

$0.00

Board Justification

No bonus was awarded for 2023 as per the summary compensation table.

Other

$666.00

Board Justification

This amount represents life insurance premiums paid by the company on behalf of the CEO.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was reported as vested in 2023.

Performance Metrics

The performance metrics for the CEO's compensation are tied to company performance, including revenue and Adjusted EBITDA targets.

Other Pulmonx Corporation CEOs

Here are other CEOs of Pulmonx Corporation

Steven S. Williamson

CEO of Pulmonx Corporation

February 2024 - Present